Uncategorized

FDA Approves “First-in-Class” Nasal Antihistamine (Astepro Allergy) For OTC

Clark Richardson Participates in June 2021 FDA Public Workshop on the OTC Drug Facts Label

PEGUS Announces Even More Enhancements to Its “Decentralized” Research Model

Brandon Henrie Promoted to Vice President – Finance and Strategy

FDA Approves New Combination Pain Reliever (Advil Dual Action) for OTC

Analysis of Data Collection Methodolgies Published in SelfCare

FDA Approves Reintroduction of OTC Primatene Mist

PEGUS Presentation on OTC Consumer Research at 2018 CHPA RSQ Conference

Clark Richardson Presents at April 2018 CHPA Consumer Behavior Roundtable

Study Conducted by PEGUS Research Published in JAPhA